ScholarIQanswers from OpenAlex
First People's Hospital of Foshan
InstitutionResearch output, impact & collaborations
First People's Hospital of Foshan is a institution indexed in ScholarIQ from OpenAlex.
What is known about First People's Hospital of Foshan?
ScholarIQrecord summary
First People's Hospital of Foshan is a research organisation in Foshan, CN. OpenAlex records 4,765 works and 128,598 citations for it. 1,723 researchers list it as their most recent affiliation.
How many works does First People's Hospital of Foshan have?
ScholarIQindexed works
First People's Hospital of Foshan has 4,765 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does First People's Hospital of Foshan have?
ScholarIQcitation count
First People's Hospital of Foshan has 128,598 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at First People's Hospital of Foshan?
ScholarIQresearcher count
First People's Hospital of Foshan has 1,723 researchers in the ScholarIQ index.
What is the average h-index at First People's Hospital of Foshan?
ScholarIQavg h-index
First People's Hospital of Foshan has an average h-index of 21 in OpenAlex.
What is the ROR of First People's Hospital of Foshan?
ScholarIQror
The ROR for First People's Hospital of Foshan is on the source record.
What is the OpenAlex record for First People's Hospital of Foshan?
ScholarIQopenalex
The OpenAlex for First People's Hospital of Foshan is on the source record.
Who are the most-cited researchers behind First People's Hospital of Foshan?
ScholarIQtop researchers by citations
What are the most-cited papers on First People's Hospital of Foshan?
ScholarIQmost cited works
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
Yunpeng Yang, Song Qu, Jingao Li, Chaosu Hu, Mingjun Xu, Weidong Li, Ting Zhou, Liangfang Shen, Hui Wu, Jinyi Lang, G. Hu, Zhanxiong Luo, Zhichao Fu, Shenhong Qu, Weineng Feng, Xiaozhong Chen, Shaojun Lin, Weimin Zhang, Xiaojiang Li, Yan Sun, Zhixiong Lin, Qin Lin, Lei Feng, Jianting Long, Jinsheng Hong, Xiaoming Huang, Lingzhi Zeng, Peiguo Wang, Xiaohui He, Ben Zhang, Qing Yang, Xiao‐Jing Zhang, Jianjun Zou, Wenfeng Fang, Li Zhang
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant
HARMONi-A Study Investigators, Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo, Runxiang Yang, Yan Huang, Zhiyong He, Hui Zhao, Mingjun Li, Kai Li, Qibin Song, Xiaobo Du, Yulan Sun, Wei Li, Fei Xu, Zhiyu Wang, Kunning Yang, Yun Fan, Baogang Liu, Hongyun Zhao, Ying Hu, Lee Jia, Xu Shen, Tienan Yi, Dongqing Lv, Haitao Lan, Mengxia Li, Wenhua Liang, Yongsheng Wang, Hui Yang, Yuming Jia, Yuan Chen, Jun‐Guo Lu, Jifeng Feng, Chunling Liu, Ming Zhou, Jianya Zhou, Xianling Liu, Ningning Zhou, Ming He, Xiaorong Dong, Hualin Chen, Yongxing Chen, Haichuan Su, Xiaoling Li, Zhihong Zhang, Lei Yang, Ying Cheng, Likun Chen, Xue Hou, Yu Zhang, Jun Guo, Zhen Wang, Hong Lu, Di Wu, Weineng Feng, Wen Li, Jian‐An Huang, Yan Wang, Xia Song, Jiewen Peng, Laiyu Liu, Yubiao Guo, Wenting Li, Dongmei Lu, Mingxiu Hu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Li Zhang
Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network
Chao Zhang, Xing Sun, Kang Dang, Ke Li, Xiaowei Guo, Chang Jia, Zongqiao Yu, Feiyue Huang, Yunsheng Wu, Yunsheng Wu, Zhu Liang, Zaiyi Liu, Xue-gong Zhang, Xinglin Gao, Shaohong Huang, Jie Qin, Weineng Feng, Tao Zhou, Yanbin Zhang, Wei-jun Fang, Mingfang Zhao, Xue‐Ning Yang, Qing Zhou, Yi‐Long Wu, Yi‐Long Wu, Wen‐Zhao Zhong
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
Yunpeng Yang, Jianya Zhou, Jianying Zhou, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong, Yanqiu Zhao, Yiping Zhang, Yong Song, Yi Hu, Zhuang Yu, Youling Gong, Yuan Chen, Feng Ye, Shucai Zhang, Lejie Cao, Yun Fan, Gang Wu, Yubiao Guo, Chengzhi Zhou, Kewei Ma, Jian Fang, Weineng Feng, Yunpeng Liu, Zhendong Zheng, Gaofeng Li, Ning Wu, Wei Song, Xiaoqing Liu, Shijun Zhao, Lieming Ding, Li Mao, Giovanni Selvaggi, Xiaobin Yuan, Yuanqing Fu, Tao Wang, Shanshan Xiao, Li Zhang
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer
Ziyou Lin, Jingwei Li, Jian Zhang, Weineng Feng, Jiaye Lu, Xiaofan Ma, Wen Ding, Shumin Ouyang, Jin‐Jian Lu, Peibin Yue, Guohui Wan, Peiqing Liu, Xiaolei Zhang
How much of the research on First People's Hospital of Foshan is open access?
ScholarIQopen access share
73%OPEN ACCESS